Free Trial

Apyx Medical (APYX) Short Interest Ratio & Short Volume

Apyx Medical logo
$1.44 -0.08 (-5.26%)
Closing price 01/31/2025 03:59 PM Eastern
Extended Trading
$1.36 -0.09 (-5.90%)
As of 01/31/2025 04:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Apyx Medical Short Interest Data

Apyx Medical (APYX) has a short interest of 148,600 shares, representing 0.46% of the float (the number of shares available for trading by the public). This marks a 17.56% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.5, indicating that it would take 2.5 days of the average trading volume of 33,005 shares to cover all short positions.

Current Short Interest
148,600 shares
Previous Short Interest
126,400 shares
Change Vs. Previous Month
+17.56%
Dollar Volume Sold Short
$211,012.00
Short Interest Ratio
2.5 Days to Cover
Last Record Date
January 15, 2025
Outstanding Shares
37,640,000 shares
Float Size
32,040,000 shares
Short Percent of Float
0.46%
Today's Trading Volume
23,075 shares
Average Trading Volume
33,005 shares
Today's Volume Vs. Average
70%
Short Selling Apyx Medical?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Apyx Medical and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

APYX Short Interest Over Time

APYX Days to Cover Over Time

APYX Percentage of Float Shorted Over Time

Apyx Medical Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/15/2025148,600 shares $211,012.00 +17.6%0.5%2.5 $1.42
12/31/2024126,400 shares $199,712.00 +1.8%0.4%2.2 $1.58
12/15/2024124,200 shares $208,656.00 +3.5%0.4%2.3 $1.68
11/30/2024120,000 shares $193,200.00 -14.6%0.4%2.3 $1.61
11/15/2024140,500 shares $177,030.00 -39.0%0.5%3.3 $1.26
10/31/2024230,300 shares $269,451.00 -2.0%0.8%5.7 $1.17
10/15/2024234,900 shares $277,182.00 -0.5%0.8%6.4 $1.18
9/30/2024236,100 shares $292,764.00 -3.2%0.8%6.4 $1.24
9/15/2024243,900 shares $282,924.00 -8.0%0.8%6.9 $1.16
8/31/2024265,100 shares $352,583.00 -10.7%0.9%7.6 $1.33
8/15/2024296,900 shares $409,722.00 +4.0%1.0%7.8 $1.38
7/31/2024285,600 shares $388,416.00 +1.8%1.0%5.3 $1.36
7/15/2024280,600 shares $384,422.00 -3.7%1.0%5.2 $1.37
6/30/2024291,500 shares $390,610.00 -2.5%1.0%4.9 $1.34
6/15/2024298,900 shares $433,405.00 -8.7%1.1%2.5 $1.45
5/31/2024327,500 shares $540,375.00 -20.6%1.2%2.3 $1.65
5/15/2024412,600 shares $581,766.00 -23.6%1.5%2.8 $1.41
4/30/2024540,300 shares $772,629.00 +45.6%1.9%3.7 $1.43
4/15/2024371,100 shares $512,118.00 -47.5%1.3%2.4 $1.38
3/31/2024706,700 shares $961,112.00 -55.0%2.5%4.4 $1.36
3/15/20241,570,000 shares $2.81 million -1.3%5.2%10.1 $1.79
2/29/20241,590,000 shares $3.34 million +1.3%5.3%15.8 $2.10
2/15/20241,570,000 shares $3.36 million +4.0%5.2%14 $2.14
1/31/20241,510,000 shares $3.38 million -3.2%5.0%10.6 $2.24
1/15/20241,560,000 shares $3.46 million -1.9%5.2%10.8 $2.22
12/31/20231,590,000 shares $4.17 million -1.9%5.3%10 $2.62
12/15/20231,620,000 shares $3.81 million +1.3%5.4%9.9 $2.35
11/30/20231,600,000 shares $3.78 million -20.8%5.3%9.9 $2.36
11/15/20232,020,000 shares $3.01 million -9.0%6.7%13.7 $1.49
10/31/20232,220,000 shares $5.08 million -7.1%7.4%14.3 $2.29
10/15/20232,390,000 shares $5.63 million -8.1%7.9%12.3 $2.36
9/30/20232,600,000 shares $8.32 million -3.4%8.6%13 $3.20
9/15/20232,690,000 shares $10.52 million -5.6%8.9%10.8 $3.91
8/31/20232,850,000 shares $13.28 million -16.7%9.4%10.6 $4.66
8/15/20233,420,000 shares $16.25 million +39.6%11.3%12 $4.75
7/31/20232,450,000 shares $13.70 million -13.4%8.1%7 $5.59
7/15/20232,830,000 shares $17.09 million +9.7%9.4%9 $6.04
6/30/20232,580,000 shares $12.98 million -27.9%8.5%8.9 $5.03
6/15/20233,580,000 shares $24.88 million -3.5%11.9%14.9 $6.95
5/31/20233,710,000 shares $23.48 million -35.1%12.3%16.7 $6.33
Is this Elon’s true agenda? (Ad)

All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them

5/15/20235,720,000 shares $32.03 million +17.5%18.9%23.5 $5.60
4/30/20234,870,000 shares $16.56 million +3.4%16.1%34.7 $3.40
4/15/20234,710,000 shares $14.13 million +12.7%15.6%27.7 $3.00
3/31/20234,180,000 shares $12.04 million +1.7%13.8%21.2 $2.88
3/15/20234,110,000 shares $10.77 million +25.7%13.6%19.2 $2.62
2/28/20233,270,000 shares $10.63 million +2.5%10.8%14.7 $3.25
2/15/20233,190,000 shares $10.53 million +4.6%10.6%13.2 $3.30
1/31/20233,050,000 shares $8.91 million +146.0%10.1%8 $2.92
1/15/20231,240,000 shares $3.21 million +42.5%4.1%3.5 $2.59
12/30/2022870,400 shares $2.04 million -5.0%2.9%2.7 $2.34
12/15/2022916,400 shares $1.76 million -3.0%3.0%3 $1.92
11/30/2022944,700 shares $1.66 million -21.9%3.1%3.2 $1.76
11/15/20221,210,000 shares $2.11 million +42.6%4.0%4.1 $1.74
10/31/2022848,800 shares $4.24 million +10.4%2.8%6.5 $5.00
10/15/2022768,600 shares $3.15 million +8.2%2.6%6 $4.10
9/30/2022710,600 shares $3.19 million +49.8%2.4%5 $4.49
9/15/2022474,300 shares $2.91 million -3.1%1.6%2.1 $6.14
8/31/2022489,200 shares $2.80 million -19.3%1.6%1.9 $5.73
8/15/2022606,100 shares $4.53 million -28.1%2.0%0.8 $7.47
7/31/2022842,500 shares $7.97 million +25.3%2.8%1.1 $9.46
7/15/2022672,600 shares $5.04 million -13.2%2.2%0.9 $7.50
6/30/2022775,000 shares $4.54 million -58.8%2.7%1 $5.86
6/15/20221,880,000 shares $11.37 million -33.1%6.5%2.5 $6.05
5/31/20222,810,000 shares $17.06 million +138.1%9.3%4.1 $6.07
5/15/20221,180,000 shares $4.31 million +21.8%3.9%7.9 $3.65
4/30/2022968,500 shares $3.65 million +25.6%3.2%7.4 $3.77
4/15/2022771,100 shares $4.13 million +40.6%2.6%6.9 $5.35
3/31/2022548,600 shares $3.58 million +12.4%1.8%5.4 $6.53
3/15/2022488,300 shares $2.87 million +11.1%1.6%5.6 $5.87
2/28/2022439,500 shares $4.45 million +7.9%1.5%7.8 $10.12
2/15/2022407,300 shares $4.29 million +18.0%1.4%6.3 $10.53
1/31/2022345,200 shares $3.97 million -10.6%1.2%4.6 $11.50
1/15/2022386,000 shares $4.49 million +11.7%1.3%5.1 $11.63
12/31/2021345,600 shares $4.43 million -2.4%1.2%4.8 $12.82
12/15/2021354,100 shares $4.49 million -5.9%1.2%3.5 $12.69
11/30/2021376,100 shares $5.05 million -7.6%1.3%3.8 $13.43
11/15/2021407,000 shares $6.63 million -14.3%1.4%4.2 $16.30
10/29/2021475,000 shares $6.79 million -5.9%1.6%5.3 $14.30
10/15/2021504,500 shares $6.63 million -6.9%1.7%5.9 $13.15
9/30/2021542,100 shares $7.51 million +10.0%1.8%6.4 $13.85
9/15/2021492,800 shares $5.48 million +2.9%1.6%6.5 $11.11
8/31/2021478,900 shares $5.66 million +5.0%1.6%6.1 $11.81
8/13/2021456,300 shares $4.98 million +0.9%1.5%5.8 $10.91
7/30/2021452,100 shares $4.07 million -0.8%1.5%5.7 $9.00
7/15/2021455,900 shares $4.17 million -0.6%1.5%5.5 $9.14
6/30/2021458,500 shares $4.73 million -15.7%1.5%5 $10.31
6/15/2021544,100 shares $5.52 million -4.6%1.8%7.2 $10.15
5/28/2021570,400 shares $5.58 million +2.6%1.9%7.3 $9.79
5/14/2021555,800 shares $5.39 million +9.2%1.9%6.4 $9.70
4/30/2021508,900 shares $5.16 million -5.3%1.7%6.1 $10.14
Is this Elon’s true agenda? (Ad)

All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them

4/15/2021537,200 shares $5.07 million -7.7%1.8%5.9 $9.44
3/31/2021581,800 shares $5.75 million -6.1%1.9%6.1 $9.88
3/15/2021619,300 shares $7.12 million -0.7%2.1%7 $11.49
2/26/2021623,700 shares $6.56 million +10.3%2.1%7.4 $10.51
2/12/2021565,500 shares $5.79 million +4.3%1.9%6.7 $10.24
1/29/2021542,000 shares $5.13 million +4.3%1.8%6.5 $9.47
1/15/2021519,900 shares $4.81 million -1.4%1.7%6.6 $9.26
12/31/2020527,000 shares $3.94 million +1.9%1.8%8.9 $7.48
12/15/2020517,200 shares $3.59 million +0.5%1.7%9.1 $6.94
11/30/2020514,700 shares $3.98 million +0.9%1.7%9.2 $7.73
11/15/2020510,100 shares $3.42 million -0.4%1.7%8.9 $6.71
10/30/2020512,100 shares $3.00 million -3.9%1.7%8.9 $5.86
10/15/2020532,700 shares $2.95 million +1.2%1.8%8.5 $5.53
9/30/2020526,600 shares $2.48 million +2.4%1.8%7.9 $4.71
9/15/2020514,100 shares $2.58 million -0.2%1.7%6.1 $5.01
8/31/2020515,300 shares $2.37 million -13.9%1.7%4.6 $4.59
8/14/2020598,600 shares $3.03 million -10.4%2.0%5.1 $5.07
7/31/2020668,000 shares $3.00 million +10.7%2.2%5.1 $4.49
7/15/2020603,700 shares $2.97 million +6.4%2.0%4.6 $4.92
6/30/2020567,300 shares $3.15 million +43.6%1.9%4.2 $5.55
6/15/2020395,200 shares $1.92 million -11.0%1.3%3 $4.87
5/29/2020443,800 shares $1.97 million +24.2%1.5%3.7 $4.44
5/15/2020357,400 shares $1.29 million -3.1%1.2%3 $3.61
4/30/2020368,900 shares $1.38 million -22.7%1.3%3.6 $3.73
4/15/2020477,400 shares $1.67 million -9.5%1.6%5.1 $3.49
3/31/2020527,200 shares $1.78 million -44.9%1.8%5.6 $3.37
3/13/2020957,200 shares $3.80 million -5.2%3.2%11.1 $3.97
2/28/20201,010,000 shares $3.27 million -1.0%3.4%14.6 $3.24
2/14/20201,020,000 shares $5.64 million -20.3%3.4%14.5 $5.53

APYX Short Interest - Frequently Asked Questions

What is Apyx Medical's current short interest?

Short interest is the volume of Apyx Medical shares that have been sold short but have not yet been closed out or covered. As of January 15th, traders have sold 148,600 shares of APYX short. 0.46% of Apyx Medical's shares are currently sold short. Learn More on Apyx Medical's current short interest.

What is a good short interest ratio for Apyx Medical?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APYX shares currently have a short interest ratio of 2.0. Learn More on Apyx Medical's short interest ratio.

What is a good short interest percentage for Apyx Medical?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.46% of Apyx Medical's floating shares are currently sold short.

Is Apyx Medical's short interest increasing or decreasing?

Apyx Medical saw a increase in short interest in January. As of January 15th, there was short interest totaling 148,600 shares, an increase of 17.6% from the previous total of 126,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Apyx Medical's float size?

Apyx Medical currently has issued a total of 37,640,000 shares. Some of Apyx Medical's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Apyx Medical currently has a public float of 32,040,000 shares.

How does Apyx Medical's short interest compare to its competitors?

0.46% of Apyx Medical's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Apyx Medical: Orchestra BioMed Holdings, Inc. (2.79%), Profound Medical Corp. (1.27%), The Beauty Health Company (11.33%), BrainsWay Ltd. (0.20%), KORU Medical Systems, Inc. (0.86%), Nevro Corp. (7.58%), Lakeland Industries, Inc. (2.17%), TriSalus Life Sciences, Inc. (0.75%), Sight Sciences, Inc. (3.59%), Pro-Dex, Inc. (0.89%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.18 billion), Charter Communications, Inc. ($3.91 billion), Reddit, Inc. ($3.16 billion), The Kroger Co. ($2.75 billion), International Paper ($2.57 billion), Cencora, Inc. ($2.06 billion), SoFi Technologies, Inc. ($2.06 billion), Rivian Automotive, Inc. ($2.00 billion), Live Nation Entertainment, Inc. ($1.63 billion), and Hims & Hers Health, Inc. ($1.57 billion). View all of the most shorted stocks.

What does it mean to sell short Apyx Medical stock?

Short selling APYX is an investing strategy that aims to generate trading profit from Apyx Medical as its price is falling. APYX shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Apyx Medical?

A short squeeze for Apyx Medical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APYX, which in turn drives the price of the stock up even further.

How often is Apyx Medical's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APYX, twice per month. The most recent reporting period available is January, 15 2025.




This page (NASDAQ:APYX) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners